Photo of Leo Sher

Leo Sher

  • ASSOCIATE PROFESSOR Psychiatry
Print ProfilePrint Profile

Biography

    st1:*{behavior:url(#ieooui) }Leo Sher, M.D. is an academic psychiatrist with a background in internal medicine. He is an Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and the Director of Inpatient Psychiatry at the James J. Peters Veterans’ Administration Medical Center. Dr. Sher is a Diplomate of the American Board of Psychiatry and Neurology.

    Dr. Sher has published more than 500 scientific works including 81 original research reports and 15 edited books. He is on the Editorial Board of several scientific journals and a reviewer for many journals. Dr. Sher has been the Principal Investigator of several research studies. His research work has been mostly focused on the psychobiology of mood disorders and suicidal behavior. Dr. Sher was the first researcher in North America who introduced the use of the combined dexamethasone suppression/corticotropin-releasing hormone stimulation test for psychiatric purposes. He has proposed the concept of posttraumatic mood disorder that was met with significant interest by experts in the field. Dr. Sher has also proposed a model of suicidal behavior in traumatized war veterans.

    Dr. Sher is a Corresponding Member of the European College of Neuropsychopharmacology (ECNP), a Member of the International Academy of Suicide Research (IASR), an Executive Member of the World Psychiatric Association (WPA) Section on Dual Disorders/Pathology, and a Member of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force, “Mental Disorders and General Practice.” He is the recipient of several awards and grants including the International Award for Excellence in Published Clinical Research in the Journal of Clinical Endocrinology and Metabolism. Dr. Sher is a very dedicated scientist, physician and educator.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Sher did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central